<p>During the COVID-19 pandemic, numerous SARS-CoV-2 infections remained undetected. We combined results from routine monthly nose and throat swabs, and self-reported positive swab tests, from a UK household survey, linked to national swab testing programme data from England and Wales, together with Nucleocapsid (N-)antibody trajectories clustered using a longitudinal variation of K-means (N = 185,646) to estimate the number of infections undetected by either approach. Using N-antibody (hypothetical) infections and swab-positivity, we estimated that 7.4% (95%CI: 7.0–7.8%) of all true infections (detected and undetected) were undetected by both approaches, 25.8% (25.5–26.1%) by swab-positivity-only and 28.6% (28.4–28.9%) by trajectory-based N-antibody-classifications-only. Congruence with swab-positivity was respectively much poorer and slightly better with N-antibody classifications based on fixed thresholds or fourfold increases. Using multivariable logistic regression N-antibody seroconversion was more likely as age increased between 30–60 years, in non-white participants, those less (recently/frequently) vaccinated, for lower cycle threshold values in the range above 30, and in symptomatic and Delta (vs. BA.1) infections. Comparing swab-positivity data sources showed that routine monthly swabs were insufficient to detect infections and incorporating national testing programme/self-reported data substantially increased detection. Overall, whilst N-antibody serosurveillance can identify infections undetected by swab-positivity, optimal use requires fourfold-increase-based or trajectory-based analysis.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories

  • Leslie R. Zwerwer,
  • Tim E. A. Peto,
  • Koen B. Pouwels,
  • Ann Sarah Walker,
  • David W. Eyre,
  • Nicole Stroesser,
  • Philippa C. Matthews,
  • Jia Wei,
  • Ian Diamond,
  • Ruth Studley,
  • Nick Taylor,
  • Emma Rourke,
  • Tina Thomas,
  • Dawid Pienaar,
  • Joy Preece,
  • Sarah Crofts,
  • Lina Lloyd,
  • Michelle Bowen,
  • Daniel Ayoubkhani,
  • Russell Black,
  • Antonio Felton,
  • Megan Crees,
  • Joel Jones,
  • Esther Sutherland,
  • Derrick W. Crook,
  • Emma Pritchard,
  • Karina-Doris Vihta,
  • Alison Howarth,
  • Brian D. Marsden,
  • Kevin K. Chau,
  • Lucas Martins Ferreira,
  • Wanwisa Dejnirattisai,
  • Juthathip Mongkolsapaya,
  • Sarah Hoosdally,
  • Richard Cornall,
  • David I. Stuart,
  • Gavin Screaton,
  • Katrina Lythgoe,
  • David Bonsall,
  • Tanya Golubchik,
  • Helen Fryer,
  • John N. Newton,
  • John I. Bell,
  • Stuart Cox,
  • Kevin Paddon,
  • Tim James,
  • Thomas House,
  • Julie Robotham,
  • Paul Birrell,
  • Helena Jordan,
  • Tim Sheppard,
  • Graham Athey,
  • Dan Moody,
  • Leigh Curry,
  • Pamela Brereton,
  • Ian Jarvis,
  • Anna Godsmark,
  • George Morris,
  • Bobby Mallick,
  • Phil Eeles,
  • Jodie Hay,
  • Harper VanSteenhouse,
  • Jessica Lee,
  • Sean White,
  • Tim Evans,
  • Lisa Bloemberg,
  • Katie Allison,
  • Anouska Pandya,
  • Sophie Davis,
  • David I. Conway,
  • Margaret MacLeod,
  • Chris Cunningham

摘要

During the COVID-19 pandemic, numerous SARS-CoV-2 infections remained undetected. We combined results from routine monthly nose and throat swabs, and self-reported positive swab tests, from a UK household survey, linked to national swab testing programme data from England and Wales, together with Nucleocapsid (N-)antibody trajectories clustered using a longitudinal variation of K-means (N = 185,646) to estimate the number of infections undetected by either approach. Using N-antibody (hypothetical) infections and swab-positivity, we estimated that 7.4% (95%CI: 7.0–7.8%) of all true infections (detected and undetected) were undetected by both approaches, 25.8% (25.5–26.1%) by swab-positivity-only and 28.6% (28.4–28.9%) by trajectory-based N-antibody-classifications-only. Congruence with swab-positivity was respectively much poorer and slightly better with N-antibody classifications based on fixed thresholds or fourfold increases. Using multivariable logistic regression N-antibody seroconversion was more likely as age increased between 30–60 years, in non-white participants, those less (recently/frequently) vaccinated, for lower cycle threshold values in the range above 30, and in symptomatic and Delta (vs. BA.1) infections. Comparing swab-positivity data sources showed that routine monthly swabs were insufficient to detect infections and incorporating national testing programme/self-reported data substantially increased detection. Overall, whilst N-antibody serosurveillance can identify infections undetected by swab-positivity, optimal use requires fourfold-increase-based or trajectory-based analysis.